African swine fever virus (ASFV) is a large double-stranded DNA virus that is the causative agent of a hemorrhagic disease of domestic swine. African swine fever was first described in the early 20th century, after the introduction of European pig breeds into British East Africa, now Kenya (37). African isolates of the virus tend to be highly virulent, and disease mortality rates can approach 100%. After the introduction of the virus into the Iberian Peninsula in 1957 and 1960, strains of ASFV that cause disease with moderate to subclinical symptoms emerged. The adaption of ASFV isolates to tissue culture also resulted in viruses that are attenuated in swine (13, 24) , and more recently, attenuation has been achieved through targeted gene knockout by recombination (17, 24, 41, 59) . Genetic studies show that adaption to tissue culture, the loss of virulence, and the narrowing of the host range are linked to large deletions in the viral genome (7, 8, 10, 14, 54) . Adaptation to tissue culture led to the loss of genetic information in the variable regions at the 3Ј and 5Ј ends of the genome (16, 56) and specifically for genes that encode multigene family (MGF) proteins (8, 14) . Targeted gene knockout experiments have precisely identified host range determinants (59), as well as several swine virulence determinants (2, 41, 57, 58) , in the ASFV genome.
African swine fever virus (ASFV) is a large double-stranded DNA virus that is the causative agent of a hemorrhagic disease of domestic swine. African swine fever was first described in the early 20th century, after the introduction of European pig breeds into British East Africa, now Kenya (37) . African isolates of the virus tend to be highly virulent, and disease mortality rates can approach 100%. After the introduction of the virus into the Iberian Peninsula in 1957 and 1960, strains of ASFV that cause disease with moderate to subclinical symptoms emerged. The adaption of ASFV isolates to tissue culture also resulted in viruses that are attenuated in swine (13, 24) , and more recently, attenuation has been achieved through targeted gene knockout by recombination (17, 24, 41, 59) . Genetic studies show that adaption to tissue culture, the loss of virulence, and the narrowing of the host range are linked to large deletions in the viral genome (7, 8, 10, 14, 54) . Adaptation to tissue culture led to the loss of genetic information in the variable regions at the 3Ј and 5Ј ends of the genome (16, 56) and specifically for genes that encode multigene family (MGF) proteins (8, 14) . Targeted gene knockout experiments have precisely identified host range determinants (59) , as well as several swine virulence determinants (2, 41, 57, 58) , in the ASFV genome.
Genes that are necessary for the host range and/or virulence of ASFV are implicated in controlling the host interferon (IFN) response. Thus, the removal of a macrophage host range determinant composed of MGF530 and MGF360 proteins yields a virus that increases the transcription of a number of IFN-regulated genes (3). IFN-␣ was also detected previously in the supernatant of macrophages infected with the virus lacking the host range determinant (3) . A swine virulence determinant in virulent African isolates is encoded by three MGF360 and three MGF530 genes in conjunction with the i14L (NL) gene (41) . The deletion of the i14L gene alone attenuates the European isolate E70 but not the African isolates Pretoriuskop/ 96/4 and Malawi Lil 20/1 (2, 57) . The i14L gene product is similar to the herpesvirus-infected-cell protein 34.5 (ICP34.5) (53). ICP34.5 antagonizes host cell protein synthesis shutdown induced by the activity of the IFN-inducible double-stranded-RNA-activated protein kinase PKR in response to doublestranded RNA by dephosphorylating the ␣ subunit of eukaryotic initiation factor 2 (11, 36) , and i14L has analogous activity (47) . The importance of the abilities of MGF360, MGF530, and i14L in inhibiting the host IFN response is illustrated by the observation that ASFV is sensitive to IFN-␣ (18) .
The activation of the IFN response by viral replication or mimics such as exposure to poly(I)-poly(C) leads to the expression of IFN genes and the secretion of IFN into the extracellular medium. IFN then binds to IFN-␣ receptors on the cell surface and induces a signaling cascade that leads to the differential regulation of hundreds of different genes (15) and the induction of the antiviral state within a cell. A number of the genes regulated by IFN have known antiviral properties (49) . The myxovirus resistance (Mx) genes are IFN-regulated genes that inhibit the replication of many different viruses from different taxonomic groups (21) . Most higher eukaryotes for which data are available have two or three Mx genes within their genomes; swine have two, encoding Mx1 and Mx2, as do humans, whose genes encode MxA and MxB (32) . Mx proteins are approximately 70 kDa and are GTPases of the dynamin superfamily. GTP binding but not GTPase activity is required for antiviral activity (25) . Single amino acid substitutions in the C terminus of an Mx protein can alter the antiviral activity of the protein (27, 29, 60) . Curiously, rat Mx3 and human MxB proteins are not known to exhibit any antiviral activity (20, 35) . The mode of action of Mx protein may depend on the subcellular localization of the protein (26, 61) , as murine and other rodent Mx proteins are predominately nuclear while Mx proteins of other species tend to localize to the cytoplasm (1). Despite these differing localization patterns, both nuclear murine Mx1 and cytoplasmic human MxA inhibit the replication of influenza A virus (45) . Human MxA also inhibits Thogoto virus replication by preventing the nuclear import of viral nucleocapsids (30) and inhibits La Crosse virus replication by sequestering viral nucleoprotein in perinuclear complexes, preventing genome amplification, budding, and egress (31, 46) . As yet, Mx proteins are not known to inhibit the replication of double-stranded DNA viruses. Interestingly, attenuated ASFV isolates that lack the host range determinant induce Mx proteins in macrophages (3), suggesting that Mx proteins may play a role in mediating the antiviral response to ASFV.
As a first step to investigate the role of Mx proteins in the IFN response to ASFV replication, we took advantage of wellcharacterized Vero cell lines that stably express Mx genes (4, 20, 39) . Vero cells possess the added advantage of being unable to express IFN after viral infection or poly(I)-poly(C) treatment (38) and so will not express endogenous Mx genes in the absence of exogenous IFN. Our studies demonstrate that MxA inhibited ASFV replication, blocked late gene expression, and was recruited to virus factories.
MATERIALS AND METHODS
Antibodies. Antisera TW34, R30, and SB11 that recognize ASFV proteins p34/polyprotein 220 (pp220), pY118L, and pE120R have been described previously (23, 28, 42) . Rabbit antiserum specific for the ASFV structural protein pE183L (j13L/p54) was raised using the synthetic peptide SNELDKHTYTNR QRLNEC as described previously (52) . Antiserum SB2 was raised using the peptide AKPARQGHNPATGEPI, which corresponds to amino acids 65 to 80 of pA104R. Mouse monoclonal antibody 4H3, which recognizes p73, has been described previously (12) , and mouse monoclonal antibody C18, which recognizes p30, was a gift from Dan Rock (College of Veterinary Medicine, University of Illinois at Urbana-Champaign). Mouse antibody to the ASFV capsid protein p73 (clone 17LD3) was purchased from Ingenasa. Mouse monoclonal antibody M143, which recognizes MxA, has been described previously (19) , and rabbit anti-Mx antibody was a gift from Peter Stäheli (Department of Virology, University of Freiburg). Mouse anti-␥-tubulin (clone GTU-88) was purchased from Sigma.
Cells and viruses. (20) and were grown in DMEM-HEPES supplemented with 10% (vol/vol) fetal calf serum and 2 mg/ml G418 sulfate. The ASFV Badajoz 1971 Vero-adapted strain Ba71v has been described previously (17) .
Chemicals. Cytochalasin D, cytosine arabinofuranoside, and [5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl]-carbamic acid methyl ester (nocodazole) were purchased from Sigma and were used at final concentrations of 1 g/ml, 50 M, and 0.2 M, respectively. Recombinant porcine IFN-␣ was purchased from R&D Systems.
Digital manipulation. Merged confocal images were created digitally using a Leica LCS Lite 2.5 microscope. All images and gel scans were resized and annotated using Adobe Photoshop CS 8.0.
DNA synthesis. Subconfluent cells in petri dishes were infected with 1.0 PFU/ cell of Ba71v. After absorption, the inoculum was discarded and replaced with DMEM containing 2% (vol/vol) fetal calf serum. Sixteen hours postabsorption, cells were pulse-labeled with 3.7 ϫ 10 5 Bq/ml [methyl-3 H]thymidine (GE Healthcare) for 15 min. The cells were then washed twice with ice-cold phosphatebuffered saline (PBS) and once with ice-cold thymidine buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 5 mM MgCl 2 ) and collected into thymidine buffer by scraping. Next, cells were resuspended in 100 l of thymidine buffer containing 0.5% NP-40 and lysed on ice for 30 min. Finally, nuclei were removed by centrifugation, the cytoplasmic fraction was precipitated with trichloroacetic acid, and the level of incorporated [methyl-3 H]thymidine was determined with a PerkinElmer 1450 Microbeta counter.
Factory cross-sectional area. Infected cells were stained with antibody 4H3 to visualize the major capsid protein p73, which accounts for 30% of the total virion mass (5) and was therefore used to determine the extent of the viral factory. Images of factories representing 0.5-m-thick serial sections through the z plane at a magnification of ϫ60 were collected. Images were deconvolved and composited together to generate an image representing the maximum cross-sectional area of the factory. Regions of interest around the p73 signal that did not correspond to cytosolic virions (28) were identified, and the cross-sectional area of a given viral factory was determined using the Openlab 3.1.7 measurement module. Statistical analyses of the data sets were run using Minitab 15.1.0.0.
Indirect immunofluorescence. Cells were fixed onto coverslips (VWR) with either 4% (wt/vol) paraformaldehyde in PBS or methanol and permeabilized with 0.2% (vol/vol) Triton X-100 (Sigma). The binding of primary antibodies was visualized using suitable secondary antibodies conjugated to Alexa 488 or Alexa 594 (Molecular Probes) as appropriate. DNA was visualized with 500 ng/ml DAPI (4Ј,6-diamidino-2-phenylindole; Sigma), and coverslips were mounted with Flouromount G (Southern Biotechnology). For digital deconvolution, cells were viewed at a magnification of ϫ60 (1.4 numerical aperture) with a Nikon E800 microscope. Images were then captured with a Hamamatsu C-4746A charge-coupled device camera and deconvolved using Improvision Openlab 3.1.7. For confocal imaging, cells were viewed at a magnification of ϫ63 (1.4 numerical aperture), and images were captured sequentially with a Leica TCS SP2 confocal microscope. Scale bars on merged confocal images represent 10 m.
Plaque assays. Confluent monolayers of cells in 24-well plates were inoculated for 1 h with serial dilutions of virus; the inoculum was then discarded, and the cells were overlaid with modified Eagle's medium containing 2% fetal calf serum and 1% type VII agarose (Sigma). Cells infected with Ba71v were fixed with 10% formaldehyde in PBS 7 days later. After fixation, overlays were removed and cell sheets were stained with 0.5% (wt/vol) crystal violet in a 20:80 methanol-water mixture for 30 min, rinsed with water, and allowed to dry prior to plaque counting.
Transfections. Vero cells were grown on coverslips and then transfected with plasmids encoding human MxA or porcine Mx1, which were kindly provided by Daniel Desmecht (44), by using TransFast reagent (Promega). Cells were cultured for 48 h in DMEM-HEPES supplemented with 2% (vol/vol) fetal calf serum before infection with Ba71v.
Transmission electron microscopy. Transmission electron microscopy was carried out as described previously (22) . Briefly, cells were grown on Thermanox coverslips and fixed 16 h postinfection for 1 h in phosphate-buffered 2% (wt/vol) glutaraldehyde solution before being fixed for a further 2 h in aqueous 1% (wt/vol) osmium tetroxide at room temperature. Following a dehydration series in ethanol, coverslips were washed with propylene oxide before infiltration with 50% epoxy resin (Agar Scientific) in propylene oxide for 30 min. After a further 60 min in 100% epoxy resin, coverslips were placed (cell side up) in 18-mmdiameter plastic cups (TAAB Laboratories Equipment Ltd.) and covered in fresh epoxy resin, and the resin was polymerized overnight at 60°C. The coverslips were then removed, and the resin was incubated at 60°C for a further 24 h. Finally, 60-m sections were cut and grid stained using EMStain (Leica Microsystems) before being imaged by an FEI Tecnai 12 transmission electron microscope with a TVIPS F214 digital camera.
Western blotting. Cell lysates in immunoprecipitation buffer (10 mM Tris [pH 7.5], 150 mM NaCl, 1% [vol/vol] IGEPAL CA-630, 10 mM iodoacetamide, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml leupeptin, 1 mg/ml pepstatin, 1 mg/ml chymostatin, 1 mg/ml antipain) were prepared. The protein VOL. 83, 2009 MxA INHIBITS AFRICAN SWINE FEVER VIRUS 2311
on October 24, 2017 by guest http://jvi.asm.org/ content was determined using a bicinchoninic acid protein assay kit (Pierce Biotechnology). Lysates were resolved on sodium dodecyl sulfate-polyacrylamide gels and transferred onto Hybond-C nitrocellulose membranes (Amersham). Membrane blocking and secondary incubations were carried out in a solution of 5% (wt/vol) skim milk powder in Tris-buffered saline containing 0.2% Tween 20 at room temperature. Primary-antibody incubations were carried out in a solution of 5% (wt/vol) bovine serum albumin in Tris-buffered saline containing 0.2% Tween 20 at 4°C overnight. Secondary antibodies conjugated to horseradish peroxidase were purchased from Promega. Bands were revealed by using a SuperSignal West Pico chemiluminescent substrate (Pierce Biotechnology).
RESULTS
MxA protein inhibits ASFV replication. Stably transfected Vero cell lines expressing human MxA or MxB were used to investigate whether Mx gene products inhibited the replication of ASFV. VN36 (control), VA3 (MxA-expressing), or VB22 (MxB-expressing) cells (20) were infected with the ASFV strain Ba71v and assayed for their abilities to support plaque formation (Fig. 1A) . Ba71v plaques were apparent in monolayers of VN36 and VB22 cells, but not in those of VA3 cells. This result showed that MxA, but not MxB, inhibited ASFV replication. At high multiplicities of infection (MOI) with ASFV, there was extensive cell death in the MxA-expressing population (data not shown), and close inspection of VA3 cells infected at lower MOI revealed a small number of rounded cells (Fig. 1B) . The detection of a cytopathic effect (CPE) on MxA-expressing cells in the absence of plaque growth suggested that virus could infect but not produce infectious progeny in the presence of the protein. This explanation was tested by analyzing the replication of Ba71v in MxA-expressing and control cells. The two cell types were infected with 0.5 PFU per cell, and infection was allowed to progress until a complete CPE on control cells was observed. The determination of progeny virus titers revealed that titers of ASFV in VA3 cells were approximately 2 logs lower than those in control VN36 cells (Fig. 1C ). These observations confirmed that MxA expression inhibited the replication of ASFV, a large double-stranded DNA virus. VA3 cells provide a useful model for analyzing the effect of Mx proteins on viral replication, but the level of MxA expression in VA3 cells is 50 to 100 times higher than that induced in human hepatoma cells by IFN (51) . It was therefore important to compare MxA expression in VA3 cells to swine Mx1 expression in pig cells. PK-15 porcine endothelial cells were incubated with or without 200 U/ml recombinant porcine IFN-␣ for 24 h. Lysates were prepared from these cells, as well as VN36 and VA3 cells, and the levels of Mx proteins were determined by immunoblotting using samples with known protein concentrations (Fig. 1D ). This analysis suggested that VA3 cells expressed MxA at approximately twice the level at which PK-15 cells expressed swine Mx1.
Mutations in the C terminus of MxA lead to proteins with altered antiviral specificities (60) . Amino acid E645 of MxA is critical for activity against influenza A virus, but not vesicular stomatitis virus or bunyaviruses, and was therefore tested for its ability to interfere with ASFV replication. VA(E645R) cells, which stably express the E645R mutant form of MxA, were infected with Ba71v and assayed for their ability to support plaque formation (Fig. 1A ) and virus growth (Fig. 1C) . The plaque phenotype of cells expressing mutant MxA differed from those of control cells and cells expressing nonmutant MxA; however, VA(E645R) cells did permit plaque formation at levels similar to those seen in control cells. Furthermore, the replication of ASFV in VA(E645R) cells was similar to that in control cells (Fig. 1C) . These observations indicated that amino acid E645 of MxA is necessary for activity against ASFV, like influenza A virus.
MxA reduces ASFV late protein synthesis. In order to determine the stage in the life cycle of ASFV inhibited by MxA, control and MxA-expressing cells were infected overnight with Ba71v and the steady-state levels of a number of ASFV proteins were determined by immunoblotting (Fig. 2A) . The first panel of Fig. 2A shows the results of immunoblotting with antibody C18, which recognizes the major early protein p30. including the major capsid protein p73 ( Fig. 2A, second In order to determine if there was an overall decrease in viral replication in MxA-expressing cells or if individual cells were replicating virus normally, the average cross-sectional area of viral factories was analyzed. The results of a twosample t test evaluating the mean cross-sectional areas of virus factories measured in VN36 and VA3 cells (t ϭ 7.43; P Ͻ 0.0005) showed that there was a twofold reduction in the size of viral factories in MxA-expressing cells compared to that in controls (Fig. 2B) . This finding suggests that MxA expression restricts the growth of viral factories in cells in which late gene expression does occur.
The transcription of late ASFV genes is dependent on the synthesis of viral DNA (48) , and the inhibition of viral DNA synthesis may explain the low levels of late proteins in MxAexpressing cells. To explore this possibility, cytoplasmic incorporation of tritiated thymidine into VN36 and VA3 cells that had been mock infected or infected for 16 h with Ba71v (33) was analyzed. The amounts of [ 3 H]thymidine recovered from the cytoplasm of infected cells, both control and MxA-expressing cells, were greater than that recovered from the cytoplasm of mock-infected cells (Fig. 2C ). This finding indicates that MxA does not prevent cytoplasmic incorporation of [ 3 H]thymidine and therefore does not inhibit viral DNA synthesis.
The inhibition of ASFV replication is associated with the recruitment of MxA to perinuclear viral assembly sites. MxA protein binds the nucleoprotein of La Crosse virus and sequesters the viral protein at perinuclear sites in the cell (31, 46) . Since ASFV assembly occurs in perinuclear viral factories (23) , the localization of MxA in cells replicating ASFV was investigated. Virus factories in control cells (Fig. 3A to D) and MxAexpressing cells (Fig. 3E to H) were compared by staining for the major capsid protein p73. A number of large perinuclear viral factories and associated intracellular virions were detected in ASFV-infected control cells, which did not stain with the anti-MxA antibody. Four MxA-expressing cells are shown in Fig. 3G ; the two on the right side of the image are uninfected, as they lack labeling for viral protein (Fig. 3F ) and do not have extranuclear viral DNA (Fig. 3E) . The spotty granular MxA staining of the uninfected cells is similar to that described previously (31) . Strikingly, in the two infected cells on the left side of the image, the MxA protein has lost some of its granular staining and is localized to an open ring structure next to the nucleus (Fig. 3F) . The merged image clearly shows that MxA protein is surrounding the viral factory (Fig. 3H) . To determine if antiviral activity was linked to the perinuclear movement of MxA to viral factories, the localization of MxA in ASFV-infected cells expressing the E645R mutant protein was examined. The labeling of ASFV-infected cells expressing E645R mutant MxA showed that the mutant protein was not recruited to viral factories (Fig. 3I to L) . These observations suggested that there might be a causal link between the re- The recruitment of MxA to viral factories was studied in greater detail using antibody TW34, which recognizes both the polypeptide precursor pp220 and mature structural protein p34 (23) . Figure 4A to D show a group of MxA-expressing cells infected with Ba71v and stained with TW34 and anti-MxA antibodies. The cells highlighted by box 1 in Fig. 4D and shown in greater detail in Fig. 4E revealed that MxA protein was recruited not only to viral factories that contained viral structural proteins and DNA but also to factories that contained only DNA. These observations suggest that MxA recruitment to viral factories does not depend on the presence of late viral proteins. The cell in the center of box 2 was analyzed in greater detail to examine the relationship between MxA and the virus factory through the z axis of an infected cell. Sections 1.1 m apart are presented in Fig. 4F to H and show that MxA is associated with the viral factory throughout the z plane of the cell.
MxA protein recruitment to ASFV factories requires DNA synthesis and is not dependent on microtubules or actin. The dependence of MxA recruitment on viral DNA synthesis was tested by infecting cells in the presence of the deoxycytidine analog cytosine arabinofuranoside (AraC), which inhibits cellular and viral DNA replication (48) . Figure 5A to D show that viral DNA synthesis is necessary for the movement of MxA protein to perinuclear sites. Note the lack of colocalization between MxA and the diminished p30 staining in perinuclear areas indicated by arrows that show the beginnings of the viral factory (50) . This result suggests that early events in factory formation do not induce MxA recruitment and that the movement of MxA to perinuclear sites is dependent on virus structural proteins or DNA synthesis.
The interaction between MxA and La Crosse virus nucleocapsid protein is not dependent on the microtubule or actin networks (46) . To determine if MxA recruitment to ASFV factories was dependent on elements of the cytoskeleton, cells were infected with Ba71v and then treated with either nocodazole or cytochalasin D. Nocodazole and cytochalasin D depolymerize microtubules and actin, respectively, and so prevent microtubule-or actin-dependent intracellular transport. Virus factories were visualized using DAPI labeling (Fig. 5E and I) , and anti-MxA labeling revealed that the MxA protein was recruited to factories in the presence of both nocodazole (Fig.  5G ) and cytochalasin D (Fig. 5K) . Anti-␣-tubulin labeling showed that nocodazole had disrupted the microtubule network (Fig. 5F) , and the use of a phalloidin conjugate showed that the actin network was disrupted in the presence of cytochalasin D (Fig. 5J ). These data demonstrate that the microtubule and actin networks are not required for the recruitment of MxA to ASFV factories. This pattern is similar to that seen in the interaction between MxA and La Crosse virus nucleocapsid protein.
MxA protein colocalizes with the small DNA binding protein pA104R of ASFV. Mx proteins inhibit RNA viruses by interacting with the virus nucleocapsid proteins, and ASFV encodes three structural proteins with predicted DNA binding activity, pA104R, pE120R, and pK78R (9, 34, 40) . Suitable reagents to detect pK78R expression are lacking, but the localization of Control and MxA-expressing cells infected with Ba71v were stained with antisera SB2 and SB11, which recognize pA104R and pE120R, respectively (Fig. 6 ). There was little difference in the localization of pE120R between VN36 and VA3 cells ( Fig.  6B and F) , although the number of pE120R-expressing cells among the MxA-positive cells compared to that among control cells was greatly diminished, as predicted by the immunblotting results (Fig. 2) . The distribution of pA104R in control cells was quite different from that of the other viral structural proteins tested, as pA104R localized predominately to the nucleus but could also appear in the cytoplasm and the virus factory (Fig.  6J) . Strikingly, in the MxA-expressing cells, there was an absence of nuclear pA104R staining and most of the viral protein encircled the viral factory (Fig. 6N) , colocalizing with MxA (Fig. 6P ). These observations suggest that MxA protein may interact with the ASFV DNA binding protein pA104R.
Association of filaments with ASFV viral factories in MxAexpressing cells. The ring structures formed by MxA in response to ASFV were investigated at the ultrastructural level to help provide an understanding of their relationship to the virus factory. MxA-expressing cells infected with ASFV were imaged with the electron microscope, and the results are displayed in Fig. 7 . Virus factories seen in MxA-expressing cells (Fig. 7B to D) appeared to have fewer mature and immature virus particles and lower levels of viroplasm, viral membranes, and zipper structures than virus factories seen in VN36 cells infected with ASFV (Fig. 7A ). This finding is consistent with the reduction in factory size seen by immunofluorescence (Fig. 2B) . Also noticeable in MxA cells were unusual filaments that appeared to surround the virus factory (Fig. 7) . Similar structures in VA3 cells infected with La Crosse virus have been identified previously (31) . These filaments are shown in detail in comparison to a zipper structure (Fig. 7D ) and a pair of immature virions lacking nucleoprotein cores (Fig. 7C) . nucleus (Fig. 8C) . This pattern was similar to that seen previously in stably transfected VA3 cells (Fig. 3G and 6O ). In the merged image (Fig. 8D) , the MxA ring appeared to encircle the viral protein and DNA ( Fig. 8A and B) . Similar results were obtained for the cells transfected with porcine Mx1. M143 staining revealed a perinuclear ring structure (Fig. 8G ) that surrounded the viral replication site (Fig. 8E,  F, and H) . This pattern showed that like human MxA, porcine Mx1 was recruited to viral factories after infection with ASFV.
DISCUSSION
IFN has an important role in controlling ASFV infection, and here we have shown that an effector of the IFN response can suppress viral replication in tissue culture. ASFV replicated poorly in cells stably transfected with human MxA protein, yielding 2-log-fewer progeny than control cells in virus replication experiments (Fig. 1) . Virus entry and the initiation of the early stages of the viral life cycle were not affected by MxA, as the steady-state levels of the early protein p30 were not affected ( Fig. 2A) . MxA appeared to target the late stage of virus replication, as the levels of critical structural proteins were observed to be low compared to those in controls ( Fig.  2A) . This finding is likely to be linked to an effect on late transcription or translation because viral DNA synthesis was not significantly reduced compared to that in controls (Fig.  2C) . MxB, which has no known antiviral activity, did not inhibit ASFV replication.
Stably expressed MxA protein localizes to granular struc- 
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MxA INHIBITS AFRICAN SWINE FEVER VIRUS 2317 tures in the cytoplasm (31), while ASFV replicates in perinuclear cytoplasmic factories that resemble aggresomes (23, 43, 55) . Immunolabeling of infected cells showed that MxA was recruited from the cytoplasm to perinuclear sites of replication, where the protein surrounded the virus factories ( Fig. 3H  and 4D to H). Confocal analysis of a virus factory revealed that MxA was associated with the replication site throughout the z plane of the cell (Fig. 4F to H) . The observation that MxA could be detected surrounding virus factories that did not appear to contain structural proteins (Fig. 4E) , together with the observation that MxA was not recruited to perinuclear sites in the absence of DNA synthesis (Fig. 5A to D) , suggests that the target for anti-ASFV activity may be viral DNA. However, Mx proteins are not known to interact with nucleic acid and viral DNA synthesis was not inhibited by MxA (Fig. 2C) . Low levels of structural proteins may be present in virus factories but may be beneath the detection limit of indirect immunofluorescence assays.
Mutations in the C terminus of MxA generate proteins with altered antiviral specificities. The E645R point mutation eliminates anti-influenza A virus (orthomyxovirus) and anti-La Crosse virus (bunyavirus) activities but not anti-vesicular stomatitis virus (rhabdovirus) activity. Cells expressing mutant MxA supported control levels of ASFV plaque formation and virus replication, indicating that the E645R point mutation inhibited anti-ASFV (Asfarviridae) activity as well. This outcome demonstrated the specificity of the antiviral effect of MxA on ASFV because a single amino acid change eliminated the ability of MxA to inhibit ASFV replication. E645R mutant MxA was not recruited to virus factories, suggesting that the anti-ASFV activity of MxA was linked to movement to perinuclear sites. Perinuclear accumulations of MxA and La Crosse nucleocapsid complexes are characterized by stacks of filamentous bundles (31) and are not dependent on the microtubule or actin networks (46) . These filamentous structures were also seen in ASFV-infected MxA cells (Fig. 7) , and the recruitment of MxA to ASFV factories was not dependent on cytoskeletal elements (Fig. 5E to L) . These observations suggest that MxA exerts an antiviral effect on ASFV, a large double-stranded DNA virus, and La Crosse virus, a negative-sense RNA virus, through a common mechanism.
ASFV does not have a nucleoprotein as such but is known to encode at least three DNA binding proteins. The gene products of the A104R, E120R, and K78R open reading frames are all structural proteins with experimental DNA binding activity (9, 34, 40) . However, suitable reagents for pK78R are lacking, and we were unable to evaluate this viral protein further. Immunofluorescence labeling showed that pA104R, but not pE120R, colocalized with MxA in the perinuclear structures that surround ASFV factories in MxA-expressing cells (Fig. 6 ). The lack of interaction between MxA and pE120R is perhaps not surprising because the principal role of pE120R in the virus life cycle is now considered to be the microtubule-mediated movement of virions out of the factory to the plasma membrane (6) . The observation that pA104R colocalized with MxA suggested that these proteins may interact. However, ASFV has more than 150 open reading frames, and other viral proteins for which we do not have reagents may also colocalize with MxA. Ascribing a function to the potential interaction between MxA and pA104R is complex, because the expression of pA104R is heavily repressed by MxA (Fig. 2A) . The inhibitory effect of MxA may be exerted on pA104R from parental virus rather than pA104R that is synthesized during infection. Alternatively, late ASFV gene expression may be amplified through a positive feedback loop mediated by pA104R. Sequestering newly synthesized pA104R outside of the virus factory would essentially stall gene expression at a low basal level. However, not enough is known about the mechanisms that govern late ASFV transcription and translation to draw firm conclusions.
Recent evidence points to an important role for the host IFN response in limiting the host range and virulence of ASFV (3, 41, 59) . Here, we provide evidence for a potential effector of this limitation by demonstrating that MxA protein can inhibit the replication of ASFV. The recruitment of transiently expressed porcine Mx1 to viral factories (Fig. 8) shows that the pig homolog interacts with ASFV in a manner analogous to that of MxA but is clearly not definitive proof of antiviral activity. Experiments to test this idea and also to investigate the importance of porcine Mx1 in the inhibition of ASFV replication by IFN (18) are planned. This is the first description of an Mx gene's inhibiting a large double-stranded DNA virus. Furthermore, MxA appears to inhibit ASFV in a manner analogous to that of its inhibition of the bunyavirus La Crosse virus.
